Navigation Links
Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
Date:5/29/2009

With all of the new treatments available for incontinence nowadays, an effective and easy solution is within reach for men and women struggling with incontinence. The main roadblock to that solution might just be the patient himself, by minimizing the severity of his condition. Dr. Peter Muench of Delaware Urologic Associates in Newark, Delaware, knows this all too well and advises patients that full disclosure is the best policy in helping them with their condition. Hopefully, with enough publicity about these advances in the treatment of both male and female incontinence, more patients will speak up and get their condition cured.

Newark, Delaware (PRWEB) May 29, 2009 -- In the past, a big fear for males undergoing either radical prostatectomy for prostate cancer or trimming for a blocking prostate (BPH) was urinary incontinence. Incontinence after radical prostatectomy will generally occur in about 2% of cases. Leakage after an over-aggressive trimming of a prostate for blockage occurs less often, but it's not unheard of.

Of course, the cases of male incontinence can vary by degrees depending on their perspective. After radical prostatectomy, men are often more willing to cope with their leakage than to undergo yet another procedure. A successful treatment is the American Medical Systems 800TM Urinary Control System, also known as an artificial urinary sphincter (AUS). It is the only artificial urinary sphincter currently on the market. For over 30 years, physicians worldwide have surgically implanted the device in more than 94,000 men as a treatment for stress [urinary incontinence due to prostatectomy.

However, many patients who leak mildly or moderately, using 1-4 pads per day, feel that an AUS is too invasive, because of the degree of their
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
2. Growth in Delaware Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
3. Universal Capital Management Reports Top Delaware Surgeon to Join Advisory Board
4. Delaware Youth Shares Epilepsy Message on Capitol Hill
5. Silverman, McDonald & Friedman Opens New Office in New Castle to Serve Legal Needs of Delaware Families
6. HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference
7. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
8. AARP Survey Reveals Boomers Health Care Needs in Delaware
9. AARP Represents the Pulse of Delawareans 50+: Survey Reveals Attitudes about Health Care in Delaware
10. PA Department of Health Urges Sexually Active Individuals in Delaware County to Get STD Tests
11. Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
(Date:5/4/2015)... 2015 In May of 2010, after two ... life. In the wake of this tragedy, Ty’s parents Kirk ... that exposes the grim reality of bullying and its devastating ... Kirk and Laura to share their story and offer education ... to another family — a mission that took the Smalley ...
(Date:5/4/2015)... May 04, 2015 The U.S. healthcare ... boomers join the ranks of senior citizens (1) and ... an already over-burdened healthcare system. Additionally, as older healthcare ... replace them. Per the U.S. Census Bureau, the number ... increase 75% by 2050 while those 25 to 54 ...
(Date:5/4/2015)... Ticket Down is a reputable source for ... . While the World Cup is the most known ... years, the International Champions Cup is one of the biggest ... attendance record for soccer in the United States set when ... the University of Michigan. This year, the defending champion Manchester ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4
... to Demonstrate Single-Agent Activity, - 38% Response Rate, 43% Disease Control ... Refractory Hodgkin Lymphoma ... in 110mg Cohort, ... Including an 18% Response Rate in Evaluable Diffuse Large B- cell ...
... that has saved more than 100,000 lives, now is saving ... disease progression with long term use in adults with chronic ... continues to show how much Gleevec has completely changed the ... Druker, M.D., director of the OHSU Cancer Institute. , ...
... ATLANTA, GA, December 8, 2007 -- Results from two ... with bortezomib provide preliminary anti-tumor activity in patients with ... study showed that 10 of 21 (48 percent) evaluable ... ZOLINZA and bortezomib combination treatment. Data from a ...
... 8, 2007 There is a clear link between GABA ... that inhibits neurons in the brain and ... the American College of Neuropsychopharmacology (ACNP) annual meeting. Researchers ... a finding which could potentially help curb the pleasurable ...
... Boca Raton, FL, December 8, 2007 Bipolar disorder, ... the circadian system the bodys internal clock ... irregularities in the circadian system that can trigger key ... today at the American College of Neuropsychopharmacology (ACNP) annual ...
... Dec. 7 On the heels of today,s,Human ... immigrant,detainees, AIDS Healthcare Foundation (AHF) today criticized the ... disregard for the,health and well-being of people living ... Indifference: HIV/AIDS Services for Immigrants,Detained by the U.S.," ...
Cached Medicine News:Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 2Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 3Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 4Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 5Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 6Health News:Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting 7Health News:Gleevec, the targeted cancer pill, delivers more good news to patients 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Study suggests nicotine addiction might be controlled by influencing brain mechanisms 2Health News:Studies find stable sleep patterns and regular routines may improve outcomes in bipolar disorder 2Health News:Studies find stable sleep patterns and regular routines may improve outcomes in bipolar disorder 3Health News:Denial of Care for HIV+ Detainees 'Unacceptable,' Says AHF 2
(Date:5/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... comprehensive overview of the company,s corporate responsibility efforts. ... approach to corporate responsibility by increasingly leveraging its ... have greater, more sustainable impact. The ... thorough look at the company,s progress on numerous ...
(Date:5/4/2015)... NASHVILLE, Tenn. , May 4, 2015  Verus ... after its acquisition of CPAP Care Club in 2012.  ... CPAP business within the durable medical equipment (DME) industry ... apnea patients for their CPAP supply needs and processes ... we bought this company three years ago, the systems ...
(Date:5/4/2015)... , May 4, 2015 CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... countries worldwide, will report Q1 2015 financial results ... 2015.  CytoSorbents, management will host ... will recount both operational and financial progress during ...
Breaking Medicine Technology:Lilly Releases Corporate Responsibility, Global Health Reports 2Lilly Releases Corporate Responsibility, Global Health Reports 3Lilly Releases Corporate Responsibility, Global Health Reports 4Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... for maintaining a healthy immune systemPURCHASE, N.Y., Jan. 6 ... Cancer (60(5), 643-651) by researchers at Kansai Medical ... Hexose Correlated Compound) enhances immune function by increasing the ... part of the immune system responsible for presenting foreign ...
... 6 Pacira Pharmaceuticals, Inc., an,acute care specialty ... in two pivotal Phase III SIMPLE trials to ... administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative analgesia. , ... in hemorrhoidectomy and in total knee,arthroplasty (TKA) are ...
Cached Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
Medicine Products: